158 related articles for article (PubMed ID: 24075744)
1. A difference in systolic blood pressure between arms is a novel predictor of the development and progression of diabetic nephropathy in patients with type 2 diabetes.
Okada H; Fukui M; Tanaka M; Matsumoto S; Iwase H; Kobayashi K; Asano M; Yamazaki M; Hasegawa G; Nakamura N
Atherosclerosis; 2013 Oct; 230(2):198-201. PubMed ID: 24075744
[TBL] [Abstract][Full Text] [Related]
2. A difference in systolic blood pressure between arms and between lower limbs is a novel risk marker for diabetic nephropathy in patients with type 2 diabetes.
Okada H; Fukui M; Tanaka M; Matsumoto S; Mineoka Y; Nakanishi N; Asano M; Yamazaki M; Hasegawa G; Nakamura N
Hypertens Res; 2013 May; 36(5):403-7. PubMed ID: 23324865
[TBL] [Abstract][Full Text] [Related]
3. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes.
Okada H; Fukui M; Tanaka M; Inada S; Mineoka Y; Nakanishi N; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
Atherosclerosis; 2012 Jan; 220(1):155-9. PubMed ID: 22100253
[TBL] [Abstract][Full Text] [Related]
4. Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes.
Okada H; Fukui M; Tanaka M; Matsumoto S; Mineoka Y; Nakanishi N; Asano M; Yamazaki M; Hasegawa G; Nakamura N
Diabetes Care; 2013 Jul; 36(7):1908-12. PubMed ID: 23340892
[TBL] [Abstract][Full Text] [Related]
5. Morning pulse pressure is associated more strongly with elevated albuminuria than systolic blood pressure in patients with type 2 diabetes mellitus: post hoc analysis of a cross-sectional multicenter study.
Ushigome E; Fukui M; Hamaguchi M; Matsumoto S; Mineoka Y; Nakanishi N; Senmaru T; Yamazaki M; Hasegawa G; Nakamura N
Diabetes Res Clin Pract; 2013 Sep; 101(3):270-7. PubMed ID: 23871575
[TBL] [Abstract][Full Text] [Related]
6. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
[TBL] [Abstract][Full Text] [Related]
7. Home-measured heart rate is associated with albuminuria in patients with type 2 diabetes mellitus: a post-hoc analysis of a cross-sectional multicenter study.
Ushigome E; Fukui M; Hamaguchi M; Tanaka T; Atsuta H; Ohnishi M; Tsunoda S; Yamazaki M; Hasegawa G; Nakamura N
Hypertens Res; 2014 Jun; 37(6):533-7. PubMed ID: 24621466
[TBL] [Abstract][Full Text] [Related]
8. Visit-to-visit variability in systolic blood pressure predicts development and progression of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes.
Takao T; Matsuyama Y; Yanagisawa H; Kikuchi M; Kawazu S
J Diabetes Complications; 2014; 28(2):185-90. PubMed ID: 24332763
[TBL] [Abstract][Full Text] [Related]
9. Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients.
Sheen YJ; Lin JL; Li TC; Bau CT; Sheu WH
J Diabetes Complications; 2014; 28(6):779-84. PubMed ID: 25219331
[TBL] [Abstract][Full Text] [Related]
10. Optimal home SBP targets for preventing the progression of diabetic nephropathy in patients with type 2 diabetes mellitus.
Ushigome E; Hamaguchi M; Matsumoto S; Oyabu C; Omoto A; Tanaka T; Fukuda W; Hasegawa G; Mogami S; Ohnishi M; Kitagawa Y; Tsunoda S; Oda Y; Nakamura N; Fukui M
J Hypertens; 2015 Sep; 33(9):1853-9; discussion 1859. PubMed ID: 26136206
[TBL] [Abstract][Full Text] [Related]
11. [Development of blood pressure level over a three years period in non-insulin dependent diabetic subjects according to their microalbuminuria].
Mayaudon H; Bauduceau B; Ducorps M; Belmejdoub G; Poirier JM
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1045-9. PubMed ID: 8949376
[TBL] [Abstract][Full Text] [Related]
12. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
[TBL] [Abstract][Full Text] [Related]
13. Heart rate-corrected QT interval is a novel risk marker for the progression of albuminuria in people with Type 2 diabetes.
Hashimoto Y; Tanaka M; Senmaru T; Okada H; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Nakamura N; Fukui M
Diabet Med; 2015 Sep; 32(9):1221-6. PubMed ID: 25683576
[TBL] [Abstract][Full Text] [Related]
14. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
Theilade S; Hansen TW; Rossing P
Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
[TBL] [Abstract][Full Text] [Related]
15. Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?
Bouchi R; Ohara N; Asakawa M; Nakano Y; Takeuchi T; Murakami M; Sasahara Y; Numasawa M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2016 Jan; 15():10. PubMed ID: 26790628
[TBL] [Abstract][Full Text] [Related]
16. Maximum home blood pressure is a useful indicator of diabetic nephropathy in patients with type 2 diabetes mellitus: KAMOGAWA-HBP study.
Oyabu C; Ushigome E; Matsumoto S; Tanaka T; Hasegawa G; Nakamura N; Ohnishi M; Tsunoda S; Ushigome H; Yokota I; Tanaka M; Asano M; Yamazaki M; Fukui M
Diab Vasc Dis Res; 2017 Nov; 14(6):477-484. PubMed ID: 28819987
[TBL] [Abstract][Full Text] [Related]
17. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
[TBL] [Abstract][Full Text] [Related]
18. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
Kanaoka T; Tamura K; Moriya T; Tanaka K; Konno Y; Kondoh S; Toyoda M; Umezono T; Fujikawa T; Ohsawa M; Dejima T; Maeda A; Wakui H; Haku S; Yanagi M; Mitsuhashi H; Ozawa M; Okano Y; Ogawa N; Yamakawa T; Mizushima S; Suzuki D; Umemura S
Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452
[TBL] [Abstract][Full Text] [Related]
19. [Role of nocturnal blood pressure in the onset of diabetic nephropathy].
Garcia C; Mayaudon H; Bordier L; Le Berre JP; Dupuy O; Bauduceau B
Arch Mal Coeur Vaiss; 2007 Aug; 100(8):668-72. PubMed ID: 17928773
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
